Yale and Alexion Report: Advance in Spinal Cord Repair
Edit Page
Report
Scan day: 20 February 2014 UTC
41
Virus safety - good
Description: The report, entitled "Xenotransplantation of Transgenic Pig Myelin Forming Cells Promotes Axonal Regeneration and Restores Conduction Across the transected spinal cord," is based on research conducted in the laboratories of Dr. Jeffrey D. Kocsis of the Department of Neurology, Yale University School of Medicine, and Dr. William L. Fodor, Senior Director of Xenotransplantation at Alexion Pharmaceuticals, Inc. and their colleagues.
Yale and Alexion report advance in spinal cord repair Public release date: 24-Oct-1999 Yale and Alexion report advance in spinal cord repair NAGOYA, JAPAN, Oct. 25, 1999 -- Researchers from the Yale University School of Medicine and Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported that transplanting genetically modified pig cells into surgically damaged spinal cords of non-human primates can regenerate the myelin sheath around the injured fragment of the spinal cord. Alexion believes that these results represent a critical milestone in progressing its spinal cord product into patient trials.
Size: 609 chars
Contact Information
Email:Send Message
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Yale and Alexion report advance in spinal cord repair |
| Keywords: | Biology Medicine/Health Clinical Trials Technology/Engineering/Computer Science Biotechnology |
| Description: | Researchers from the Yale University School of Medicine and Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported that transplanting genetically modified pig cells into surgically damaged spinal cords of non-human primates can regenerate the myelin sheath around the injured fragment of the spinal cord. |
| IP-address: | 198.151.217.228 |